Common Stock, Shares, Issued of Regen BioPharma Inc from Q3 2013 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Regen BioPharma Inc quarterly Common Stock, Shares, Issued history and change rate from Q3 2013 to Q2 2025.
  • Regen BioPharma Inc Common Stock, Shares, Issued for the quarter ending 30 Jun 2025 was 31.6M shares, a 622% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Regen BioPharma Inc Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 31.6M +27.2M +622% 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 21.6M 31 Mar 2025 10-Q 28 May 2025
Q4 2024 21.6M +17.8M +475% 31 Dec 2024 10-Q 16 May 2025
Q3 2024 5.26M +1.75M +50% 30 Sep 2024 10-Q 11 Aug 2025
Q2 2024 4.37M 30 Jun 2024 10-Q 13 Aug 2024
Q4 2023 3.75M 31 Dec 2023 10-Q 19 Jan 2024
Q3 2023 3.51M +152K +4.52% 30 Sep 2023 10-K 13 May 2025
Q3 2022 3.35M -4.35B -99.9% 30 Sep 2022 10-K 13 May 2025
Q1 2022 4.58B +1.65B +56.1% 31 Mar 2022 10-Q 21 Apr 2022
Q4 2021 4.56B +2.3B +102% 31 Dec 2021 10-Q 20 Jan 2022
Q3 2021 4.35B +2.75B +171% 30 Sep 2021 10-K 15 Nov 2022
Q2 2021 3.78B +2.18B +136% 30 Jun 2021 10-Q/A 22 Dec 2021
Q1 2021 2.93B +2.77B +1728% 31 Mar 2021 10-Q 18 Aug 2021
Q4 2020 2.26B +838M +58.9% 31 Dec 2020 10-Q 13 Aug 2021
Q3 2020 1.61B +1B +167% 30 Sep 2020 10-K 22 Dec 2021
Q2 2020 1.61B +1.09B +210% 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 161M -217M -57.4% 31 Mar 2020 10-Q 05 Aug 2021
Q4 2019 1.42B +1.17B +464% 31 Dec 2019 10-Q 05 Aug 2021
Q3 2019 600M +420M +233% 30 Sep 2019 10-Q 05 Aug 2021
Q2 2019 518M +360M +227% 30 Jun 2019 10-Q 24 Oct 2019
Q1 2019 377M +226M +149% 31 Mar 2019 10-Q 29 Aug 2019
Q4 2018 252M +106M +72.4% 31 Dec 2018 10-Q 12 Feb 2019
Q3 2018 180M +40.6M +29.1% 30 Sep 2018 10-K 21 Jun 2021
Q2 2018 159M +20.6M +14.9% 30 Jun 2018 10-Q 06 Aug 2018
Q1 2018 151M +13.2M +9.57% 31 Mar 2018 10-Q 14 May 2018
Q4 2017 146M +145M +14518% 31 Dec 2017 10-Q 06 Feb 2018
Q3 2017 140M -8.45K -0.01% 30 Sep 2017 10-K 27 Dec 2018
Q2 2017 138M +3.56M +2.65% 30 Jun 2017 10-Q 07 Aug 2017
Q1 2017 138M +9.86M +7.69% 31 Mar 2017 10-Q 05 May 2017
Q4 2016 1M -123M -99.2% 05 Jan 2017 10-K 05 Jan 2018
Q3 2016 140M +25M +21.8% 30 Sep 2016 10-Q 27 Jan 2017
Q2 2016 135M +21M +18.5% 30 Jun 2016 10-Q/A 28 Apr 2017
Q1 2016 128M +18.9M +17.3% 31 Mar 2016 10-Q/A 28 Apr 2017
Q4 2015 124M +72.2M +139% 31 Dec 2015 10-Q/A 28 Apr 2017
Q3 2015 115M +63.1M +122% 30 Sep 2015 10-Q/A 28 Apr 2017
Q2 2015 114M +61.6M +119% 30 Jun 2015 10-Q/A 28 Apr 2017
Q1 2015 109M +57.4M +111% 31 Mar 2015 10-Q 07 May 2015
Q4 2014 52M 31 Dec 2014 10-Q 04 Feb 2015
Q3 2014 51.6M 0 0% 30 Sep 2014 10-K/A 28 Apr 2017
Q2 2014 51.9M 30 Jun 2014 10-Q 07 Aug 2014
Q1 2014 51.9M 31 Mar 2014 10-Q 05 May 2014
Q3 2013 51.6M 30 Sep 2013 10-K 18 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.